Neurocrine Biosciences (NBIX) Non-Current Deffered Revenue (2010 - 2018)
Neurocrine Biosciences (NBIX) recorded Non-Current Deffered Revenue of $10.23 million in Q4 2018, unchanged from $10.23 million a year earlier and unchanged from the prior quarter.
Neurocrine Biosciences (NBIX) Non-Current Deffered Revenue (2010 - 2018) Analysis & Trends
Starting with Q4 2010, Neurocrine Biosciences' Non-Current Deffered Revenue history includes 23 quarters.
- Annual Non-Current Deffered Revenue has a three-year compound annual growth rate of 0.0% (FY2015 to FY2018).
- Across earlier years, Non-Current Deffered Revenue came in at $10.23 million in FY2017 (unchanged), $10.23 million in FY2016 (unchanged) and $10.23 million in FY2015.
- Per Business Quant, the preceding three quarters came in at $10.23 million (Q3 2018), $10.23 million (Q2 2018) and $10.23 million (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 10.23 Mn |
| Sep 30, 2018 | 10.23 Mn |
| Jun 30, 2018 | 10.23 Mn |
| Mar 31, 2018 | 10.23 Mn |
| Dec 31, 2017 | 10.23 Mn |
| Sep 30, 2017 | 10.23 Mn |
| Jun 30, 2017 | 10.23 Mn |
| Mar 31, 2017 | 10.23 Mn |
| Dec 31, 2016 | 10.23 Mn |
| Sep 30, 2016 | 10.23 Mn |
| Jun 30, 2016 | 10.23 Mn |
| Mar 31, 2016 | 10.23 Mn |
| Dec 31, 2015 | 10.23 Mn |
| Sep 30, 2015 | 10.23 Mn |
| Jun 30, 2015 | 10.23 Mn |
| Mar 31, 2015 | 10.23 Mn |
| Sep 30, 2012 | 728,000.00 |
| Jun 30, 2012 | 1.46 Mn |
| Mar 31, 2012 | 2.19 Mn |
| Dec 31, 2011 | 2.92 Mn |
Neurocrine Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();